One in 50 people have brain aneurysms, a disorder where a weak artery wall can rupture into a massive
brain bleed. One third of ruptured brain aneurysm patients die and one third of survivors suffer permanent
brain damage. Oxford Endovascular is a university spin-out in its final stage of development of a next
generation flow-diverter that has the potential to transform treatment in a $1billion market, growing at
over 8%. The technology is a unique patent protected design developed by world leading experts and the
company is led by medtech veterans who have successfully commercialised cutting edge devices.

свернуть